The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical cardiology"
DOI: 10.1002/clc.23807
Abstract: BACKGROUND The duration of beta-blocker therapy in patients without heart failure (HF) or left ventricular systolic dysfunction after acute myocardial infarction (AMI) is unclear. HYPOTHESIS Continuous beta-blocker therapy is associated with an improved prognosis. METHODS… read more here.
Keywords: beta blocker; continuous beta; blocker therapy;